Previous close | 0.9100 |
Open | 0.8900 |
Bid | 0.9100 |
Ask | 0.9400 |
Strike | 25.00 |
Expiry date | 2025-01-17 |
Day's range | 0.8900 - 0.9500 |
Contract range | N/A |
Volume | |
Open interest | 59.17k |
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).